Systematic review with meta‐analysis: high mortality in patients with non‐severe alcoholic hepatitis
Open Access
- 23 June 2019
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 50 (3) , 249-257
Abstract
Summary: Background: Alcoholic hepatitis is a serious complication of alcohol misuse. Severe alcoholic hepatitis with its high mortality, has been investigated in detail but ‘nonsevere alcoholic hepatitis’ is poorly characterised. Survival of this group of patients is unknown.Aim: To conduct a systematic review and meta‐analysis to determine 28‐day, 90‐day and 1‐year mortality of patients with nonsevere alcoholic hepatitis.Methods: The protocol was registered on the PROSPERO database (CRD42018107451). Embase, Medline and Cochrane Central databases were searched until July 2018. All study designs reporting mortality rates in patients with nonsevere alcoholic hepatitis were eligible. Mortality data were extracted and meta‐analysis performed using a random effects model. Risk of bias was assessed by Cochrane risk of bias or National Institutes of Health quality assessment tool for case series studies.Results: Twenty‐five studies (n = 1372 patients; 12 prospective) met criteria. Nonsevere was variably defined based on bilirubin, prothrombin time, and creatinine. Twenty‐eight day mortality (17 studies; n = 993) was 6% (95% CI 3%‐9%; I2 = 67.3%; P < 0.001), 90‐day mortality (15 studies; n = 755) was 7% (4%‐11%, I2 = 64.2%; P < 0.001) and 1‐year mortality (five studies; n = 234) was 13% (4%‐24%; I2 = 72%; P = 0.006). Subgroup analyses by method of diagnosis (histological vs clinical) or study design (prospective vs retrospective) did not reveal differences in mortality.Conclusion: Nonsevere alcoholic hepatitis is not benign with 6% and 13% 28‐day and 1‐year mortality, respectively. This systematic review demonstrates the paucity of high quality studies in patients with nonsevere alcoholic hepatitis. Our analysis suggests that patients who do not meet criteria for severe alcoholic hepatitis are an important and hitherto overlooked clinical group. Full characterisation of clinical outcome and development of treatment strategies to reduce mortality in this group is a priority.Keywords
This publication has 49 references indexed in Scilit:
- The Utility of Scoring Systems in Predicting Early and Late Mortality in Alcoholic Hepatitis: Whose Score Is It Anyway?International Journal of Hepatology, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Clinical Characteristics and Mortality of Hospitalized Alcoholic Hepatitis Patients in the United StatesJournal of Clinical Gastroenterology, 2011
- Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studiesJournal of Hepatology, 2006
- Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis scoreGut, 2005
- MELD accurately predicts mortality in patients with alcoholic hepatitis†Hepatology, 2005
- Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitisJournal of Hepatology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Relationship of Protein Calorie Malnutrition to Alcoholic Liver Disease: A Reexamination of Data from Two Veterans Administration Cooperative StudiesAlcohol, Clinical and Experimental Research, 1995
- Transformations Related to the Angular and the Square RootThe Annals of Mathematical Statistics, 1950